Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 21NIH 2NETWORK 1INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Genitourinary 1Classical hematology 1

Conditions

Neoplasms 51Lung Neoplasms 32Lymphoma 31Breast Neoplasms 29Multiple Myeloma 27Prostatic Neoplasms 25Melanoma 23Carcinoma, Non-Small-Cell Lung 23Leukemia, Myeloid, Acute 22Neoplasm Metastasis 21Ovarian Neoplasms 20Lymphoma, Non-Hodgkin 20Hematologic Neoplasms 20Glioma 18Pancreatic Neoplasms 17Urinary Bladder Neoplasms 16Neuroblastoma 15Colorectal Neoplasms 15Burkitt Lymphoma 15Carcinoma, Renal Cell 14Sarcoma 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Colonic Neoplasms 13Leukemia, Lymphocytic, Chronic, B-Cell 12Carcinoma 12Brain Neoplasms 12Triple Negative Breast Neoplasms 11Stomach Neoplasms 11Squamous Cell Carcinoma of Head and Neck 11Oropharyngeal Neoplasms 11

Interventions

Fluorodeoxyglucose F18 12-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NIH × Disease × 30 days × Clear all
NCT00001620 2026-05-29

Screening for Hematology Branch Protocols

National Institutes of Health Clinical Center (CC)

Enrolling by invitation
10,000 enrolled
Classical hematologyOther hematologic neoplasm

Cytopenia, Anemia, Disease, Hematologic Diseases, Neutropenia, Thrombocytopenia, Hematologic Neoplasms

NCT03173924 2026-05-29

18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancer

National Institutes of Health Clinical Center (CC)

Phase 2 Active not recruiting
96 enrolled
Genitourinary

Disease, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡